Quest Diagnostics Incorporated (DGX) Q1 FY26 Earnings Call

Strong organic growth and raised guidance are tempered by partnership mix, seasonal costs, and limited underlying volume excluding collaborations.

Q1 FY26 results, source: company transcript and SEC filings
QuarterQ1 FY26
Call date2026-04-21
Length59 minutes
EPS$2.50
EPS consensus$2.37
Revenue$2.9B

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26 · Q1 FY25 · Q2 FY24

All DGX earnings · Back to DGX overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.